Latest News from: Yale Cancer Center/Smilow Cancer Hospital

Filters close
Newswise: Yale Cancer Center Experts Present New Research at Leading Breast Cancer Symposium
Released: 29-Nov-2023 10:05 AM EST
Yale Cancer Center Experts Present New Research at Leading Breast Cancer Symposium
Yale Cancer Center/Smilow Cancer Hospital

Yale Cancer Center researchers at Yale School of Medicine will present new research at the 46th annual San Antonio Breast Cancer Symposium (SABCS) from December 5 to 9. The international symposium provides leading-edge breast cancer information on prevention, etiology, diagnosis, and therapy as well as experimental biology. This year’s symposium, at the Henry B.

Newswise: Yale Cancer Center Experts Present New Research at Hematology Annual Meeting
Released: 28-Nov-2023 4:05 PM EST
Yale Cancer Center Experts Present New Research at Hematology Annual Meeting
Yale Cancer Center/Smilow Cancer Hospital

Physicians and scientists from Yale Cancer Center, part of Yale School of Medicine, will present new research at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, Calif., from December 9 to 12. This year’s ASH meeting will include oral and poster presentations, workshops, and educational sessions for hematology professionals.

Newswise: Asher Marks, MD, in honor of Childhood Cancer Awareness Month
Released: 28-Sep-2023 5:05 PM EDT
Asher Marks, MD, in honor of Childhood Cancer Awareness Month
Yale Cancer Center/Smilow Cancer Hospital

What are some of the biggest challenges you face in caring for cancers in children? The biggest challenges are around supporting the parents. For the most part, children are resilient and upbeat.

Newswise: Courtney Gibson, MD, MS, FACS, in honor of Thyroid Cancer Awareness Month
Released: 18-Sep-2023 11:05 AM EDT
Courtney Gibson, MD, MS, FACS, in honor of Thyroid Cancer Awareness Month
Yale Cancer Center/Smilow Cancer Hospital

What advances have made the biggest impact in the treatment of patients with thyroid cancer over the last five years, and what is the outlook for thyroid cancer in the next five years? Molecular testing (MT) to examine somatic changes has become an important adjunct in the diagnosis and treatment of many cancers.

Newswise: Michael E. Karellas, MD, FACS, in honor of Prostate Cancer Awareness Month
Released: 18-Sep-2023 11:05 AM EDT
Michael E. Karellas, MD, FACS, in honor of Prostate Cancer Awareness Month
Yale Cancer Center/Smilow Cancer Hospital

Prostate screening is a critical part of early diagnosis. How would you encourage a man reading this to see his doctor to begin prostate screenings? The decision to screen for prostate cancer is highly individualized, considering each man’s personal risk, race, as well as other potential health conditions.

Newswise: Francine Foss, MD, in honor of Blood Cancer Awareness Month
Released: 18-Sep-2023 11:05 AM EDT
Francine Foss, MD, in honor of Blood Cancer Awareness Month
Yale Cancer Center/Smilow Cancer Hospital

As we honor lymphoma awareness month, what do you want our patients and families to pause and remember?Lymphoma is a disease which can strike any one of us, young and old, at any time.

Newswise: Early Exposure to Medicine Inspired Committed Careers
Released: 8-Jun-2023 8:05 AM EDT
Early Exposure to Medicine Inspired Committed Careers
Yale Cancer Center/Smilow Cancer Hospital

By their early 20s, two of Yale’s most prominent cancer experts had each been immersed in healthcare battles for many years. Few people would have been surprised if they chose careers outside of healthcare. Instead, Drs. Eric Winer and Patricia LoRusso chose to pursue cancer care and research as their work. Both are now leaders of two of the country’s most prestigious organizations for cancer professionals.

Newswise: HIPEC Surgery Brings Advanced Abdominal Cancer Treatment to Smilow Cancer Hospital
Released: 5-May-2023 9:30 AM EDT
HIPEC Surgery Brings Advanced Abdominal Cancer Treatment to Smilow Cancer Hospital
Yale Cancer Center/Smilow Cancer Hospital

A technique that delivers high doses of heated chemotherapy directly to the abdominal cavity is a promising treatment for certain patients with Stage IV cancer. Hyperthermic intraperitoneal chemotherapy (HIPEC) kills cancer cells in the abdomen remaining after the surgical removal of tumors.

Newswise: Raising Awareness About Colorectal Cancer
Released: 10-Mar-2023 6:25 PM EST
Raising Awareness About Colorectal Cancer
Yale Cancer Center/Smilow Cancer Hospital

With the arrival of March, Colorectal Cancer Awareness Month, faculty and staff in the Department of Internal Medicine’s Section of Digestive Diseases are redoubling their efforts to spread the word about the importance of screening, especially in younger individuals and those with a family history of the disease. Colorectal cancer is the second most common cause of cancer death in the United States.

Newswise: How Patients with Cancer Can Navigate COVID-19 for the Holidays
Released: 20-Dec-2021 8:00 AM EST
How Patients with Cancer Can Navigate COVID-19 for the Holidays
Yale Cancer Center/Smilow Cancer Hospital

Smilow Cancer Hospital expert has the latest recommendations for patients and families.

Released: 22-Jun-2018 10:05 AM EDT
Five Ways to Lower Your Skin Cancer Risk
Yale Cancer Center/Smilow Cancer Hospital

Experts at Yale Cancer Center say unless you take the right precautions, sun exposure (even if you don't get scorched) can damage your skin, causing wrinkles, age spots and even skin cancer.

Released: 3-Apr-2018 3:55 PM EDT
Yale Expert Discusses Treatment for Endometrial Cancer
Yale Cancer Center/Smilow Cancer Hospital

Dr. Alesandro Santin Discusses Treatment for Endometrial Cancer

Released: 12-Mar-2018 3:05 PM EDT
Yale Expert Available to Speak on Medical Marijuana for Children with Cancer
Yale Cancer Center/Smilow Cancer Hospital

A majority of pediatric cancer providers endorse the use of medical marijuana for children with advanced cancer, according to results of a multicenter survey published in Pediatrics.

Released: 27-Oct-2017 11:50 AM EDT
Overcoming Resistance to Immunotherapy
Yale Cancer Center/Smilow Cancer Hospital

For some cancer patients, the road to remission and healing can have its share of speed bumps. That’s particularly true of patients with non-small cell lung cancer (NSCLC) who develop a secondary, or acquired, resistance to immunotherapy, which initially was effective against their tumors.


Showing results 1 – 50 of 62


close
0.71558